Zealand Pharma A/S. - ADR

NASDAQ:ZEAL  
33.08
+0.76 (+2.35%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.46B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$9.31 Million
Adjusted EPS-$0.93
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Zealand Pharma A/S Stock, NASDAQ:ZEAL

Sydmarken 11, Soborg, Zealand 2860
Denmark
Phone: +45.88.77.36.00
Number of Employees: 179

Description

Zealand Pharma A/S is a biotechnology company that engages in the discovery, design and development of peptide based medicines. Its products include Soliqua and Lyxumia. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on October 19, 1998 and is headquartered in Soborg, Denmark.